Welcome to the CARE1 blog, check out our articles here.
Our CARE1 team was represented on site by the Project ...
Such a crystal clear, thoughtful approach to doublets from @AlbigesL as front line for metastatic #kidneycancer! Doublets are now established standard in trials AND the need for biomarkers for future patient/tx selection. Kudos for the new #CARE1 trial underway in EU! #ASCO23...
We are pleased to inform you that as part of the « Programme Hospitalier de Recherche Clinique - Volet Cancérologie – PHRC-K 2022 -2023 »...
"« We are pleased to announce the launch of #CARE1 Project, which officially started on May 1st, 2023. The project was submitted under the Call HORIZON-MISS-2022-CANCER-01-03, focused on pragmatic clinical trials to optimize treatments for patients with refractory cancers. ...
We are pleased to announce the launch of CARE1 Project, which officially started on May 1st, 2023. ...
📢 Launch of the pragmatic CARE-1 clinical trial coordinated by Pr @AlbigesL @GustaveRoussy. A key step in the future of kidney cancer care #CARE1 #ClinicalResearch #HealthCareInnovation @HorizonEU...
For further questions, including partnership opportunities, please contact using our contact form.